Notably, the data exhibited that SPRY4-IT1 expression was significantly correlated with the survival rates of CRC patients (p = 0.0075, Figure 1(B)), suggesting the effects of SPRY4-IT1 on CRC patients’ prognosis. This evidence concerns the gene HAUS3 and colorectal carcinoma.